Skip to main content

Table 1 Patient characteristics

From: Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis

  DMT-treated patients N = 14,627
Age (mean, SD), y 47.4 11.0
Age categories (n, %)
 18–24 y 341 2.3
 25–34 y 1488 10.2
 35–44 y 3885 26.6
 45–54 y 4958 33.9
 55–64 y 3161 21.6
 65–74 y 712 4.9
 75–84 y 77 0.5
 85+ y 5 0.0
Sex (n, %)
 Male 3872 26.5
 Female 10,755 73.5
Geographic region (n, %)
 Northeast 2523 17.2
 North Central 4071 27.8
 South 5139 35.1
 West 2811 19.2
 Unknown 83 0.6
Index year (n, %)
 2007 2440 16.7
 2008 3129 21.4
 2009 1923 13.1
 2010 1729 11.8
 2011 1304 8.9
 2012 1248 8.5
 2013 976 6.7
 2014 919 6.3
 2015 750 5.1
 2016 209 1.4